期刊文献+

NogoB-shRNA表达质粒的构建及其在大鼠原代肝星状细胞收缩中的作用 被引量:1

Construction of shRNA Expressing Plasmid Targeted Rat NogoB and Observation of the Effection about NogoB on Hepatic Stellate Cells
原文传递
导出
摘要 目的构建针对大鼠NogoB基因的shRNA表达质粒,并初步探究其在大鼠肝星状细胞(HSCs)收缩功能中的作用。方法设计并合成针对大鼠NogoB基因3个不同位点的shRNA,通过DNA重组技术,将shRNA插入pSuper质粒中,构建NogoB-shRNA重组质粒,转染至大鼠原代肝星状细胞(HSCs)中,并通过Realtime PCR技术检测基因的相对表达量,筛选出能沉默大鼠NogoB基因的重组质粒,再通过Western blot加以验证,同时观察NogoB基因被抑制后,HSCs中内皮素1(Endothelin-1,ET-1)受体A、受体B(ETA、ETB)表达水平的变化。结果构建的3对重组质粒中,NogoB-shRNA2对NogoB的基因的表达具有明显的抑制作用。NogoB基因被抑制后,大鼠HSCs中ETA的表达无明显变化,ETB的表达升高,ETA/ETB的水平降低。结论成功构建了有效、特异的抑制大鼠NogoB基因表达的shRNA表达质粒,并初步观察到NogoB在肝星状细胞的收缩中可能有一定作用。 Objective To construct shRNA expressing plasmid inhibiting rat NogoB and to observe its possible effect on rat primary hepatic stellate cells (HSCs) contraction. Methods Three pairs of shRNAs targeting different sequence of rat NogoB were designed and constructed into pSuper plasmid by DNA recombination technique. Culture-activated HSCs were transfected with NogoB-shRNA plasmids to scan the effective plasmid which could inhibit NogoB gene expression by Real-time PCR. And this depressant effect was also confirmed with Western blot. After NogoB was knocked-down effectively, ETA and ETB mRNA expression were assessed by Real-time PCR. Results Among the three pairs of recombinant plasmids, NogoB-shRNA2 plasmid could inhibit NogoB expression specifically. In HSCs, NogoB knockdown decreased the ratio of ETA and ETB. Conclusion We constructed specific NogoB-shRNA expression plasmid successfully which might be involved in contraction of HSCs.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2014年第3期362-366,350,共5页 Journal of Sichuan University(Medical Sciences)
基金 四川省科技厅项目(No.2013FZ0085) 四川省成都市科技厅项目(No.13PPYB994SF-014)资助
关键词 短发夹 RNA NogoB 肝星状细胞 shRNA NogoB Hepatic stellate cells
  • 相关文献

参考文献2

二级参考文献41

  • 1Wen Jie Dai,Hong Chi Jiang Second Department of General Surgery, the First Clinical School, Harbin Medical University, Harbin 150001, Heilongjiang Province, China.Advances in gene therapy of liver cirrhosis: a review[J].World Journal of Gastroenterology,2001,7(1):1-8. 被引量:34
  • 2Bandtlow CE,Loschinger J.Developmental changes in neuronal responsiveness to the CNS myelin-associated neurite growth inhibitor NI-35/250.Eur J Neurosci 1997,9:2743-2752.
  • 3Bandtlow CE,Dlaska M,Pirker S,et al.Increased expression of Nogo-A in hippocampal neurons of patients with temporal lobe epilepsy.Eur J Neurosci 2004,20:195-206.
  • 4Dupuis L,Gonzalez de Aguilar JL,di Scala F,et al.Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis.Neurobiol Dis 2002,10:358-365.
  • 5Mingorance A,Fontana X,Sole M,et al.Regulation of Nogo and Nogo receptor during the development of the entorhinohippocampal pathway and after adult hippocampal lesions.Mol Cell Neurosci 2004,26:34-49,
  • 6Jokic N,Gonzalez de Aguilar JL,Pradat PF,et al.Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity.Ann Neurol 2005,57:553-556.
  • 7Keegan BM,Noseworthy JH.Multiple sclerosis.Annu Rev Med 2002,53:285-302.
  • 8Reindl M,Khantane S,Ehling R,et al.Serum and cerebrospinal fluid antibodies to Nogo-A in patients with multiple sclerosis and acute neurological disorders.J Neuroimmunol 2003,145:139-147.
  • 9Karnezis T,Mandemakers W,McQualter JL,et al.The neurite outgrowth inhibitor Nogo A is involved in autoimmunemediated demyelination.Nat Neurosci 2004,7:736-744.
  • 10McKerracher L,David S,Jackson DL,et al.Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth.Neuron 1994,13:805-811.

共引文献12

同被引文献14

  • 1LIU J, YANG D, SHI S, et al. Overexpression of vasostatin- 1 protects hypoxia/reoxygenation injuries in cardiomyoeytes- endothelial cells transwell co-culture system [J]. Cell BiolInt, 2014,38(1) :26-31.
  • 2LINKERMANN A,GREEN D R. Necroptosis FJ]. N Engl J Med, 2014,370(5) :455-465.
  • 3LINKERMANN A, HACKL M J, KUNZENDORF U, et al. Necroptosis in immunity and ischemia-reperfusion injury[J]. Am J Transplant, 2013,13(11) :2797-2804.
  • 4OERLEMANS M I, LIU J, ARSLAN F, et al. Inhibition of RIPl-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo [J]. Basic Res Cardiol, 2012,107(4) :270.
  • 5KOSHINUMA S, MIYAMAE M, KANEDA K, et al. Com- bination of necroptosis and apoptosis inhibition enhances car- dioprotection against myocardial ischemia-reperfusion injury [J]. J Anesth, 2014,28(2) :235-241.
  • 6SONG R, ZHANG J, ZHANG L, et al. H202 Induces myo- cardial hypertrophy in H9c2 cells: a potential role of Ube3a[J]. Cardiovasc Toxicol, 2014.
  • 7LEE J H,PARK J W. Attenuated mitochondrial NADP+-de- pendent isocitrate dehydrogenase activity induces apoptosis and hypertrophy of H9c2 cardiomyocytes[J]. Biochimie, 2014,99: 110-118.
  • 8ZHAO M, SUN L, YU X J, et al. Acetylcholine mediates AMPK-dependent autophagic cytoprotection in H9c2 cells during hypoxia/reoxygenation injury [J]. Cell Physiol Bio- chem, 2013,32(3): 601-613.
  • 9TAFER H. Bioinformatics of siRNA design FJ]. Methods Mol Biol, 2014,1097 : 477-490.
  • 10MAO Z, LIU Z, CHEN L, et al. Predictive value of the sur- face-enhanced resonance Raman scattering-based MTT assay: a rapid and ultrasensitive method for cell viability in situ [J]. Anal Chem, 2013,85(15): 7361-7368.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部